HSA Product

Codipront Capsule

Product approved by Health Sciences Authority (SG)

Basic Information

Product Name

Codipront Capsule

Dosage Form

CAPSULE, EXTENDED RELEASE

Regulatory Information

Approval Number

SIN13319P

Approval Date

July 30, 2007

Forensic Classification

Pharmacy Only

Drug Type

Therapeutic

Route of Administration

ORAL

Record Created

August 10, 2023

Last Updated

June 3, 2025

ATC Business ID

XR05DA20

Company Information

ManufacturerCTS Chemical Industries Ltd

Registrant

RX PHARMA PTE. LTD.

Licence Holder

RX PHARMA PTE. LTD.

Active Ingredients

Codeine Base ( as Codeine Phosphate Hemihydrate)

Strength: 30mg

PHENYLTOLOXAMINE CITRATE EQV PHENYLTOLOXAMINE BASE

Strength: 10mg

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy